CVKD Stock Analysis: Buy, Sell, or Hold?
CVKD - Cadrenal Therapeutics, Inc. Common Stock
$1.75
0.21 (13.63%)
▲
5d:
+11.46%
30d:
-12.94%
90d:
-62.77%
WAIT
LOW Confidence
Analysis Updated: Aug 28, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When CVKD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CVKD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CVKD shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CVKD is currently trading at $1.75, which is considered oversold relative to its 30-day fair value range of $1.63 to $2.01.
Technical Outlook: Technically, CVKD is in a strong downtrend. Immediate support is located at $1.49, while resistance sits at $1.88. The stock is showing strong short-term momentum, up 13.6% recently.
Market Sentiment: CVKD scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.00 (+809.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CVKD is in a strong downtrend. Immediate support is located at $1.49, while resistance sits at $1.88. The stock is showing strong short-term momentum, up 13.6% recently.
Market Sentiment: CVKD scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.00 (+809.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.63 -
$2.01
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+13.6%)
- BULLISH: Trading 809.1% below Wall St target ($14.00)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.63 -
$2.01
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.49
Resistance Level
$1.88
Current Trend
Strong Downtrend
Technical data as of
Aug 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.45
Wall Street Target
$14.00
(+809.1%)
Share & Embed Analysis
Last updated: August 31, 2026 1:32 PM ET
Data refreshes hourly during market hours. Next update: 2:32 PM
Data refreshes hourly during market hours. Next update: 2:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVKD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 59 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 42 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 38 SELL |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 40 SELL |
